Point-Of-Care Testing To Improve Chronic Disease Management And Decrease Healthcare Costs

Point-of-care testing (POCT) using a fingerstick of blood can be performed in many settings, and studies demonstrate that this technology can improve outcomes and lower costs for patients with chronic diseases. POCT can also provide access to underserved populations, including those in rural environments. Advances like this that can improve care and reduce costs should be fostered and encouraged. POCT assays using a drop of blood can now test for HbA1c and glucose (used in diabetics), lipids, creatinine to access kidney function, C-reactive protein (used to assess infection), and electrolytes. To receive FDA clearance, these devices go through the same rigorous validation and accuracy studies that other laboratory analyzers do, thus assuring a reliable result.